A. Importance of the Multidisciplinary Approach to Gynecologic Cancers; B. Cervical Cancer and Precancerous Lesions: 1. The Biology of Human Papillomavirus and the Etiology of Female Genital Tract Cancers; 2. Cervical Cancer Prevention: HPV Vaccines; 3. Cervical Cancer Prevention: Screening and Diagnostic Accuracy; 4. Management of Cervical Dysplasia and Precancerous Lesions; 5. Management of Recurrent Cervical Cancer; 6. Multimodality Treatment of Rare Cervical Cancer; 7. Principles of Radiation Therapy for Cervical Cancer; C. Multimodality Approach to Cancer of the Uterine Corpus: 8. Surgical-Pathologic Features of Uterine Cancers; 9. Multidisciplinary Treatment of Endometriod Uterine Carcinoma; 10. Multidisciplinary Management of Serous Carcinoma of the Endometrium; 11. Multidisciplinary Approach to Diagnosis and Treatment of Uterine Sarcomas; D. Epithelial Ovarian Cancer: 12. Molecular Pathogenesis of Ovarian Cancer; 13. Current Status of Inherited Predisposition to Ovarian Cancer: Lessons From Familial Ovarian Cancer Registries in the UK and USA; 14. Surgical Management of Ovarian Cancer; 15. Recurrent Ovarian Cancer: Approach to Diagnosis and Treatment; 16. Multidisciplinary Palliative Care; E. Borderline Ovarian Tumors: 17. A Multidisciplinary Approach to Diagnosis and Treatment of Borderline Ovarian Tumors; 18. Germ Cell Tumors of the Ovary: Multidisciplinary Approach to Diagnosis and Treatment; 19. Non-Epithelial Ovarian Cancer; F. Cancer of the Vulva; 20. Multidisciplinary Approach to Diagnosis and Treatment of Early Cancer; 21. The Role of Sentinel Lymph Node Mapping; G. Gestational Trophoblastic Disease: 22. Pathogenesis and Multidisciplinary Approach to Evaluation, Diagnosis and Treatment of Molar Gestation; 23. Placental Site Trophoblastic Tumor; H. Future Directions in the Treatment of Gynecologic Cancers: 24. Laparoscopy and Robotic-Assisted Surgery in Gynecologic Oncology; 25. Innovations in Radiotherapy of Gynecologic Cancers; 26. PARP Inhibitors in Gynecologic Malignancies; 27. Hormonal Treatment in Gynecologic Oncology; 28. Genomic an Proteomic Biomarkers for Ovarian Cancer Screening, Prognosis, and Individualization of Chemotherapy; 29. Incorporating Translational Research into Treatment of Gynecologic Cancers while Balancing the Focus of Personalized Medicine; 30. Integrative Medicine in Gynecologic Oncology.